Holen Sie sich die Stockscreener-App
7.6314
0.99%
0.0714
Schlusskurs vom Vortag:
$7.56
Offen:
$7.47
24-Stunden-Volumen:
2.17M
Relative Volume:
0.30
Marktkapitalisierung:
$1.35B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-6.4129
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
+1.80%
1M Leistung:
+1.39%
6M Leistung:
+3.18%
1J Leistung:
-28.58%
1-Tages-Spanne:
$7.4101
$7.68
1-Wochen-Bereich:
$7.33
$7.81
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.63 | 1.34B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
232.04 | 39.30B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.27 | 13.71B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.65 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.25 | 7.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.35 | 6.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Barclays Initiates Coverage on Teladoc Health (TDOC) with Equal-Weight Rating | TDOC Stock News - GuruFocus
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? - TradingView
Teladoc Health (NYSE:TDOC) Now Covered by Barclays - MarketBeat
Does Teladoc’s 96% Five Year Slide Create a 2025 Opportunity After Virtual Care Push? - Yahoo Finance
Teladoc Health (NYSE:TDOC) Insider Fernando Rodrigues Sells 4,209 Shares - MarketBeat
Carlos Nueno Sells 3,897 Shares of Teladoc Health (NYSE:TDOC) Stock - MarketBeat
Adam Vandervoort Sells 5,720 Shares of Teladoc Health (NYSE:TDOC) Stock - MarketBeat
How Teladoc Health Inc. (4LL) stock compares with top peers2025 Retail Activity & Risk Managed Investment Signals - Newser
Is Teladoc Health Inc. (4LL) stock testing key supportMarket Volume Report & Safe Entry Point Alerts - Newser
Telemedicine Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue ForecastsResearchAndMarkets.com - Business Wire
What market sentiment indicators show for Teladoc Health Inc. stockGold Moves & Capital Efficient Trading Techniques - Newser
Is Teladoc Health Inc. stock nearing a technical breakoutJuly 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
Can Teladoc Health Inc. (4LL) stock reach $200 price targetJuly 2025 Recap & Safe Capital Growth Stock Tips - Newser
Teladoc Health’s Nueno sells $29k in shares By Investing.com - Investing.com South Africa
Teladoc Health CLO Vandervoort sells $42,831 in TDOC stock By Investing.com - Investing.com South Africa
Teladoc Health president Bliss sells $34,310 in stock By Investing.com - Investing.com Australia
Teladoc Health president sells $48.9k in stock By Investing.com - Investing.com Nigeria
Teladoc Health’s Nueno sells $29k in shares - Investing.com
Teladoc Health CLO Vandervoort sells $42,831 in TDOC stock - Investing.com
Officer Bliss Acquires 4,953 Of Teladoc Health Inc [TDOC] - TradingView
Best Healthcare IT Companies of 2026: The Quiet Shift No One Saw Coming - Fingerlakes1.com
Will Teladoc Health Inc. stock boost dividends furtherProduct Launch & Free Community Supported Trade Ideas - Newser
Will Teladoc Health Inc. (4LL) stock outperform small cap peers2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Will Teladoc Health Inc. stock top growth indexesQuarterly Investment Review & Long-Term Safe Return Strategies - Newser
Can Teladoc Health Inc. stock sustain revenue growthJuly 2025 Decliners & Weekly Top Gainers Alerts - Newser
Can Teladoc Health Inc. stock stage a strong rebound this quarterWeekly Trend Recap & Technical Pattern Based Signals - Newser
Will Teladoc Health Inc. stock beat EPS estimatesJuly 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
Teladoc Health (TDOC): Evaluating Valuation Following TytoCare Home Diagnostics Integration - Sahm
How Teladoc Health Inc. (4LL) stock behaves under inflation pressure2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
What insider trading reveals about Teladoc Health Inc. stockPortfolio Value Report & Accurate Buy Signal Notifications - Newser
Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report? - Yahoo Finance
Geode Capital Management LLC Increases Stake in Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health (TDOC) Surges 7.0% After TytoCare AI Diagnostics Integration Is Announced – Has the Growth Narrative Shifted? - Sahm
Himension Capital Singapore PTE. LTD. Decreases Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health to Participate in Upcoming Investor Conference - Enidnews.com
Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit - MSN
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? - AOL.com
The Technical Signals Behind (TDOC) That Institutions Follow - news.stocktradersdaily.com
B of A Securities Maintains Teladoc Health (TDOC) Neutral Recommendation - Nasdaq
Teladoc Health (TDOC): Assessing Valuation After Recent Short-Term Share Price Rebound - Yahoo Finance
Teladoc Health (TDOC): B of A Securities Lowers Price Target | T - GuruFocus
Teladoc Health (TDOC): Evaluating Valuation After TytoCare Partnership and New AI Diagnostic Integration - Sahm
Teladoc, Angi, Upwork, and ACV Auctions Shares Are Soaring, What You Need To Know - Finviz
Teladoc Health, Inc. (NYSE:TDOC) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st
Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):